1. Home
  2. TXG vs LIVN Comparison

TXG vs LIVN Comparison

Compare TXG & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$34.68

Market Cap

3.6B

Sector

Industrials

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$78.26

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
LIVN
Founded
2012
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.5B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
TXG
LIVN
Price
$34.68
$78.26
Analyst Decision
Hold
Buy
Analyst Count
15
7
Target Price
$20.25
$72.43
AVG Volume (30 Days)
3.2M
664.8K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
76.97
N/A
EPS
N/A
0.40
Revenue
$245,893,000.00
N/A
Revenue This Year
N/A
$9.79
Revenue Next Year
$7.33
$6.63
P/E Ratio
N/A
$197.00
Revenue Growth
68.06
N/A
52 Week Low
$11.17
$41.02
52 Week High
$35.65
$80.96

Technical Indicators

Market Signals
Indicator
TXG
LIVN
Relative Strength Index (RSI) 70.67 63.35
Support Level $16.11 $61.63
Resistance Level $35.65 N/A
Average True Range (ATR) 2.41 2.44
MACD 0.23 0.09
Stochastic Oscillator 91.84 75.33

Price Performance

Historical Comparison
TXG
LIVN

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: